Skip to content
Intrinsic value · Buy/Sell verdict · scores — free· 1049 Indian stocks· EOD 2026-07-31

Shree Renuka Sugars Limited

RENUKANSEConsumer Defensive
₹21.87
+0.23 (+1.06%)
Strong Sell

Quality, valuation, momentum and financial trend all sit near 11/100 — no single factor dominates.

ExpensiveSolvency risk
The bottom line

Our blended model reads Shree Renuka Sugars Limited as a Strong Sell at 11/100. At ₹21.87 there isn't enough clean financial data for a confident fair-value estimate, so we hold back an intrinsic verdict. It's sitting close to its 52-week low of ₹21.49. Financial health scores 0/100, in the distress band on the Altman Z-score, with a Piotroski F-score of 3/9. It clears 0 of 8 investability checks, with durability 7, valuation 15 and momentum 10 on our 0–100 scales.

Analysis by Ankit Sharma · StocksWizard's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.

Intrinsic value
Not enough public data to estimate a reliable fair value for this stock.

1-year price

EOD · 2026-07-31
1D
up 1.06%
1W
down 1.62%
1M
down 5.57%
3M
down 25.81%
6M
down 8.95%
1Y

52-week range

-32.77% from the 52-week high.

Trend check
Below 50-DMA₹23Below 200-DMA₹25

Price above both moving averages reads as an intact uptrend; below both, the trend is against you.

Verdict pillars

Strong Sell11
F
Financial health 0/100
Altman Z -0.07 · Distress zone

Piotroski F-score 3/9 — quality of earnings & balance sheet.

Our scores

Durability7
Valuation15
Momentum10

Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.

Investability checklist

Passed 0 of 8 checks
Each check screens one fundamentals, valuation or trend signal.
  • No data: ROE above 15%
  • No data: Low debt (D/E < 0.5)
  • Fail: Positive free cash flow
  • Fail: Revenue growth > 10%: -6%
  • No data: Earnings growing
  • Fail: Net margin ≥ 10%: -8.6%
  • Fail: Current ratio > 1.5: 0.48
  • No data: Below our fair value
  • No data: Margin of safety ≥ 20%
  • Fail: Above 200-day average
  • Fail: Above 50-day average
  • No data: Positive 1-year return
  • Fail: Altman Z in safe zone: Z -0.07
  • Fail: Piotroski ≥ 7: 3/9

Shareholding

  • Promoter62.6%
  • Institutions9.9%
  • Public & other27.5%

Promoter holding via insider stake; institutional via reported holdings.

Key fundamentals

Market cap
₹4,732 Cr
P/E ratio
P/B ratio
EPS (TTM)
₹-3.72
ROE
Debt / Equity
Profit margin
-8.6%
Free cash flow
₹-912 Cr
52-week high
₹32.53
-32.77% from high
52-week low
₹21.49
Dividend yield
Beta
-0.27
SWOT snapshot

Bull case vs bear case

Bear case

Weaknesses

  • Price below its 200-day moving average (downtrend).
  • Weak Piotroski score (3/9).

Threats

  • Rich valuation versus sector peers.
  • Balance-sheet stress — Altman Z -0.07.

About Shree Renuka Sugars Limited

Shree Renuka Sugars Limited manufactures and refines sugar through operations spanning sugar-milling, refining, trading, co-generation, distillery, and engineering segments. The company produces white and refined sugar marketed under the Madhur Pure & Hygienic Sugar brand for beverage, biscuit, snack, and confectionery manufacturers, along with ethyl alcohol and ethanol for oil marketing, potable alcohol, and chemical industries.

Shree Renuka Sugars Limited — frequently asked questions

Is Shree Renuka Sugars Limited a buy, hold or sell?

StocksWizard currently rates Shree Renuka Sugars Limited (RENUKA) a Strong Sell, based on a blended score of 11/100 across valuation, quality, momentum and price trend. This is our own model-based view, not investment advice.

Is Shree Renuka Sugars Limited financially healthy?

Shree Renuka Sugars Limited scores 0/100 on our financial-health model, placing it in the distress band on the Altman Z-score, with a Piotroski F-score of 3/9.

How has Shree Renuka Sugars Limited's share price performed?

Shree Renuka Sugars Limited is down 26% over three months, and last traded at ₹21.87. Past performance doesn't predict future returns.

Our verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.